t.karlsen
TL2 Moderator · Hyderabad
Contributes reviews on supplier material. Based in Hyderabad.
Joined 27 September 2025 · last posted 3d
77 posts, newest first. Showing up to 150.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #36 · Clinical › Bloodwork · 25 Jul 2026 · 30 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #137 · Practice › Reconstitution · 23 Jul 2026 · 1 like I read post #135 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Retatrutide mass and identity: what a report should show Replied, post #15 · Compounds › Retatrutide · 11 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Forced degradation studies: designing one that is informative Replied, post #85 · Analytics › Method validation · 26 Jun 2026 · 6 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
Revisiting: What pooling buys you and what it destroys Replied, post #66 · Evidence › Meta-analyses · 24 Jun 2026 · 0 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
Retatrutide mass and identity: what a report should show Replied, post #2 · Compounds › Retatrutide · 21 Jun 2026 · 24 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #68 · Practice › Storage & stability · 6 Jun 2026 · 4 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #54 · Practice › Interactions · 30 May 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #23 · Access › Insurance & coverage · 28 May 2026 · 18 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
A calculator that gives a right answer to the wrong question Replied, post #23 · Data & Tools › Calculators · 24 May 2026 · 22 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #101 · Practice › Interactions · 7 May 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Spike-and-recover accuracy for a peptide assay Replied, post #127 · Analytics › Method validation · 11 Apr 2026 · 32 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
What a certificate commits its issuer to — one year on Replied, post #38 · Analytics › COA interpretation · 26 Mar 2026 · 18 likes This follows post #35 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Designing a personal experiment that could change your mind — one year on Replied, post #23 · Research Methods › N-of-1 designs · 20 Mar 2026 · 9 likes Worth separating two things that post #19 runs together. When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #95 · Meta › Site feedback · 10 Mar 2026 · 1 like Feature requests: if the site would work better with a feature it does not have (better search, different filtering, new section) suggest it here with the reasoning.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #9 · Sourcing › Logistics · 2 Mar 2026 · 14 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
Peer-to-peer review: what actually happens on the call — one year on Replied, post #5 · Access › Insurance & coverage · 1 Mar 2026 · 3 likes Coming back to post #3, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Preprint servers and what screening they do Replied, post #59 · Evidence › Preprints · 17 Feb 2026 · 5 likes This follows post #56 rather than contradicting it. Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #70 · Documentation › Wiki requests · 4 Feb 2026 · 5 likes post #69 is right about the mechanism and I think understates the practical bit. Flag a page that has drifted: if you notice a maintained page has information that is…
-
Measurement error in home scales, with a worked standard deviation Started this topic · Research Methods › Statistics · 30 Jan 2026 · 11 likes Measurement error in home scales, with a worked standard deviation Writing it up because I had to work it out twice and would rather nobody else did. Comparing…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #19 · Outcomes › Body composition · 27 Jan 2026 · 2 likes Worth separating two things that post #15 runs together. Changes during titration: measuring body composition during active titration is less useful than measuring…
-
Run-in periods and the population they select Replied, post #56 · Evidence › Trials · 26 Jan 2026 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #16 · Regional › UK & Ireland · 21 Jan 2026 · 14 likes Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #90 · Practice › Side effects · 21 Jan 2026 · 32 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A partial dose because the pen emptied mid-injection Replied, post #68 · Practice › Administration · 9 Jan 2026 · 4 likes This follows post #65 rather than contradicting it. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a…
-
Designing a personal experiment that could change your mind — one year on Started this topic · Research Methods › N-of-1 designs · 6 Jan 2026 · 0 likes Designing a personal experiment that could change your mind — one year on — setting out what I have, and where I think it stops being reliable. Session topic: STEP 4 (…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #30 · Practice › Interactions · 4 Jan 2026 · 1 like Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #39 · Pharmacology › Receptor biology · 2 Jan 2026 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #33 · Devices › Pens & autoinjectors · 23 Dec 2025 · 25 likes Storage after first use: most pens can be stored at room temperature after first use, even if unrefrigerated, for a limited time (often 28 days). Check your specific…
-
Aggregates and why a purity assay may miss them entirely Replied, post #19 · Analytics › Impurities & related substances · 20 Dec 2025 · 3 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Persistent vomiting and the threshold for seeking help Replied, post #87 · Safety › Adverse events · 13 Dec 2025 · 17 likes post #86 answers the question as asked. The question underneath it is different. Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine…
-
[2026 update] Long-time reader, first-time poster Replied, post #31 · Lounge › Introductions · 7 Dec 2025 · 5 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #20 · Access › Pricing · 20 Nov 2025 · 27 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
-
[2026 update] What steady state means for the decision to escalate Replied, post #123 · Practice › Dosing & titration · 17 Nov 2025 · 1 like Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Pen dose counters: what a click does and does not guarantee Replied, post #45 · Devices › Pens & autoinjectors · 15 Nov 2025 · 6 likes Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #93 · Practice › Reconstitution · 6 Nov 2025 · 6 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #37 · Compounds › Semaglutide · 31 Oct 2025 · 24 likes Picking up post #34: that is the part I would want checked first. Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management…
-
New subcategory: rationale and scope Replied, post #85 · Meta › Announcements · 22 Oct 2025 · 1 like This follows post #82 rather than contradicting it. Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it…
-
New subcategory: rationale and scope Replied, post #64 · Meta › Announcements · 19 Oct 2025 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Tracking that stops updating and then resumes — the long version Replied, post #22 · Sourcing › Logistics · 5 Oct 2025 · 21 likes Picking up post #19: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Interim analyses and stopping rules Started this topic · Evidence › Trials · 20 Sep 2025 · 0 likes Interim analyses and stopping rules Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6 ( N Engl J Med , 2016)…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #44 · Evidence › Study critique · 13 Sep 2025 · 0 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
-
[2026 update] US compounding rules and how they changed Replied, post #33 · Regional › North America · 23 Aug 2025 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Are there stupid questions here? A staff answer, at length Replied, post #92 · Start Here › Welcome · 20 Aug 2025 · 28 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
How to read a forest plot, properly, from scratch Replied, post #8 · marked as the solution · Evidence › Trials · 23 Jul 2025 · 22 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Antibiotics and a course of something with delayed emptying Replied, post #86 · Practice › Interactions · 9 Jul 2025 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Checking someone else's arithmetic: a worked example thread Replied, post #61 · Practice › Reconstitution · 26 Jun 2025 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A report I filed that turned out to be wrong, and the correction Replied, post #117 · Sourcing › Vendor reports · 23 Jun 2025 · 20 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
Which panel is worth repeating and which is worth ignoring Replied, post #33 · Clinical › Bloodwork · 6 Jun 2025 · 1 like Picking up post #30: that is the part I would want checked first. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free…
-
Travel coolers and how long they really hold — the long version Replied, post #18 · Devices › Cold chain · 22 May 2025 · 0 likes Assessing an excursion: if a package sat at room temperature for a time, visual inspection (cloudiness, discoloration, particles) can alert you to problems. Not visible…
-
Reading an MS report that only gives you a single number Replied, post #76 · Analytics › Mass spectrometry · 11 May 2025 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #41 · Compounds › Repair & healing peptides · 3 May 2025 · 19 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #40 · Sourcing › Independent verification · 2 May 2025 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #8 · Practice › Dosing & titration · 25 Apr 2025 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
When to suspect the method rather than the sample Replied, post #113 · Analytics › Method validation · 12 Apr 2025 · 0 likes post #112 answers the question as asked. The question underneath it is different. Limits of detection and quantitation: LOD is the lowest concentration that produces a…
-
Storing a pen in use versus a pen unopened Replied, post #5 · Devices › Pens & autoinjectors · 29 Mar 2025 · 0 likes Injection duration: most pens deliver the dose over several seconds. Holding the button down for the full duration ensures complete delivery. Releasing early can result…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #72 · Documentation › Doc review · 24 Mar 2025 · 3 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #36 · Access › Insurance & coverage · 23 Mar 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 22 Mar 2025 · 4 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #38 · Analytics › Mass spectrometry · 18 Mar 2025 · 2 likes On post #34 — agreed on the reasoning, with one qualification. Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal.…
-
Retatrutide dose escalation in the published trials Replied, post #8 · Compounds › Retatrutide · 12 Mar 2025 · 0 likes Coming back to post #6, because the follow-up matters more than the original answer. TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #10 · Practice › Administration · 10 Mar 2025 · 20 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Revisiting: German, French and Dutch differences, compared Replied, post #2 · Regional › European Union · 8 Mar 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #107 · Compounds › Other compounds · 6 Mar 2025 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #138 · Evidence › Journal club · 23 Feb 2025 · 14 likes Picking up post #135: that is the part I would want checked first. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #97 · Compounds › Other compounds · 23 Feb 2025 · 28 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #12 · Documentation › Doc review · 6 Dec 2024 · 0 likes This follows post #9 rather than contradicting it. Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #31 · Sourcing › Independent verification · 14 Nov 2024 · 29 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
People with a low starting BMI: where the evidence stops Replied, post #15 · Clinical › Special populations · 14 Nov 2024 · 1 like Coming back to post #13, because the follow-up matters more than the original answer. Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #38 · Compounds › Repair & healing peptides · 12 Nov 2024 · 0 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
-
A page that has drifted out of date and needs a maintainer Replied, post #21 · Documentation › Wiki requests · 23 Oct 2024 · 8 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #5 · Compounds › Tirzepatide · 21 Oct 2024 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #78 · Access › Shortages · 12 Oct 2024 · 2 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #68 · Practice › Dosing & titration · 21 Sep 2024 · 0 likes This follows post #65 rather than contradicting it. Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives.…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #8 · Practice › Interactions · 14 Sep 2024 · 15 likes Coming back to post #6, because the follow-up matters more than the original answer. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A,…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #15 · Compounds › Tirzepatide · 13 Sep 2024 · 0 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
The C-cell question: rodent findings and their human context — what changed since Started this topic · Compounds › Semaglutide · 6 Aug 2024 · 37 likes The C-cell question: rodent findings and their human context — what changed since — setting out what I have, and where I think it stops being reliable. I have seen FLOW…